Featured Articles

News
May 06, 2021
For the first-line treatment of FL, obinutuzumab plus chemotherapy is cost-effective in comparison with rituximab-abbs or rituximab-pvvr plus chemotherapy in…
Videos
May 04, 2021
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Videos
May 04, 2021
Lucio Gordan, MD, discusses results from a study analyzing the impact of late dosing of two leuprolide acetate formulations on testosterone suppression for patients with prostate cancer.
Videos
April 27, 2021
Daniel Simmons, PharmD, MS, details a study comparing clinical outcomes and costs with a biomarker-guided approach and non-biomarker guided approach to first-line maintenance therapy for advanced ovarian cancer.
Videos
April 27, 2021
Amye Tevaarwerk, MD, discusses a survey exploring providers’ perspectives on the roles of phone- and video-based telemedicine in the oncology setting.